SARS-CoV-2 Spike Glycoprotein (4

Confirm delete?

SARS-CoV-2 Spike Glycoprotein (433-506)

Cat No: 30430

Proteins - More Proteins

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface glycoprotein (433-506) is a fragment of the SARS-CoV-2 surface glycoprotein, also known as the spike glycoprotein, encoded by the S gene in SARS-CoV-2 RNA.{53462} It contains amino a...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

coronavirus COVID19 2019-nCoV glyco-protein SARS-CoV2 SARSCoV-2 SARSCoV2 Beta-coronavirus betacorona corona

Product Overview:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface glycoprotein (433-506) is a fragment of the SARS-CoV-2 surface glycoprotein, also known as the spike glycoprotein, encoded by the S gene in SARS-CoV-2 RNA.{53462} It contains amino acids 433-506 of the full-length SARS-CoV-2 spike glycoprotein sequence. SARS-CoV-2 is a member of the Betacoronavirus genus of viruses and has 88% sequence identity with two bat-derived SARS-like CoVs.{53459} The SARS-CoV-2 genome contains approximately 30 kilobases that encode four structural proteins: spike, envelope, membrane, and nucleocapsid.{53462,49555} The SARS-CoV-2 spike glycoprotein is located on the outer envelope of the virion and is comprised of an S1 and S2 subunit divided by a furin S-cleavage site not found in other SARS-CoVs.{46767,49561} The S1 subunit contains the N-terminus and a receptor binding domain (RBD; Item No. 30429), and the S2 subunit contains a fusion peptide, two heptad repeats, and the C-terminal domain.{46767} SARS-CoV-2 is the causative agent of COVID-19, a primarily respiratory illness characterized by fever, cough, and shortness of breath that can lead to life-threatening complications.{53461,55257,55258} Cayman’s SARS-CoV-2 Spike Glycoprotein (433-506) contains the SARS-CoV-2 receptor binding motif (Item No. 30428) and a disulfide bridge between Cys480 and Cys488.

Size	1 mg
Shipping	dry ice
Purity	≥95%
Custom Code	3504.00
UNSPSC code	12352204

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.